Approval status in plain words
Is Ipamorelin FDA-Approved? No
The human trial failed to prove a benefit. Approval didn't follow, and pharmacy access grew tighter in 2024.
The failed trial and pharmacy rule both narrowed your options
Is ipamorelin FDA approved? No. No health office has cleared it for any illness [3]. Its sole published human trial followed bowel surgery patients, and the drug didn't show a clear benefit [3].
In 2024, the FDA also removed ipamorelin from a key pharmacy list [3]. Sport rules ban it at all times [7]. A seller may claim its powder meets drug-making standards. That claim doesn't prove the powder is safe, clean, or useful for you.
No review found Ipamorelin safe and useful
The FDA hasn't cleared ipamorelin for sale as medicine [3]. Europe's drug office hasn't cleared it either. There is no approved illness, label, or dose. Phase 2, the mid-stage work, ended after one failed trial [3]. The next steps would have been larger benefit tests and longer safety checks. Those never happened.
A seller may say "research-grade," meaning meant for lab work; "pharmaceutical-grade," a claim of drug-making quality; or "99% pure." None of these claims proves a health office checked the vial. An outside test would need to confirm the drug, its purity, and the lack of germs.
The trial didn't show patients could eat sooner
The trial studied bowel shutdown after surgery. Doctors call that problem postoperative ileus. It enrolled 114 adults who had part of their bowel removed. The drug went into a vein morning and evening, and treatment ended within seven days [3].
The ipamorelin group ate first, but chance could still explain the gap [3]. Both groups reported many side effects. Researchers found no clear drug-linked pattern [3].
This brief test found no clear new alarm. It also didn't prove the drug helped. No large Phase 3 trial came next.
The 2024 rule blocked one pharmacy path
Ipamorelin was once on a temporary FDA pharmacy list. The list covered 2 versions of the ingredient: ipamorelin with acetate attached and ipamorelin without it. Neither version was approved medicine. That rule changed in 2024.
The sponsor withdrew the request in September 2024. The FDA then removed ipamorelin from the list. On October 29, 2024, a public panel considered the drug's 2 versions [3].
A pharmacy can no longer use ipamorelin as a starting ingredient under that federal rule. A clinic can't create approval by calling it "medicinal." The 2024 action narrowed access; it didn't grant it [3]. The rule ended that option for pharmacy-made drugs.
Sport rules ban Ipamorelin, and urine tests find it
Athletes may not use ipamorelin at any time under World Anti-Doping Agency rules. It sits with banned hormones and growth drugs [7]. Sport labs can enforce the rule by finding the drug in urine.
One test could spot ipamorelin among 17 other banned peptides at between 50 and 500 trillionths of a gram per milliliter of urine [7]. An older test found from 2 to 10 trillionths of a gram per milliliter [8]. Another found 1 nanogram per milliliter, or one billionth of a gram in that same amount of urine [9]. These are the smallest traces the tests could see. They don't say when your urine would test clear.